Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment

Peptides and peptidomimetics in combination with t cell activating and/or checkpoint inhibiting agents for cancer treatment

US Patent 10149887 · Granted Dec 11, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phosphatidylserine-binding conjugates2025
IDO/TDO inhibitor2025
Daisy chain connection system and system control method2021
Interlocking structure, mounting member, and airbag device2016
Peptides and peptidomimetics in combination uses and treatments for cancer patie2015
Compounds with anti-cancer activity2013
Compounds with anti-cancer activity2011
Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cel2010
Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augme2010
Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augme2009
Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and an2009
Peptides and peptidomimetics having anti-proliferative activity and/or that augm2009